MSR1 is not required for obesity-associated inflammation and insulin resistance in mice

被引:0
作者
Nance, Sierra A. [1 ,2 ]
Muir, Lindsey [3 ]
Delproprosto, Jennifer [2 ]
Lumeng, Carey N. [1 ,2 ]
机构
[1] Univ Michigan, Mol & Integrat Physiol, Med Sch, 109 Zina Pitcher Pl,2057 BSRB, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Pediat, Med Sch, 109 Zina Pitcher Pl,2057 BSRB, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Computat Med & Bioinformat, Med Sch, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
ADIPOSE-TISSUE; LOCAL PROLIFERATION; INTERLEUKIN-6; PROTECTION; ALPHA;
D O I
10.1038/s41598-023-29736-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Obesity induces a chronic inflammatory state associated with changes in adipose tissue macrophages (ATMs). Macrophage scavenger receptor 1 (MSR1) has been implicated in the regulation of adipose tissue inflammation and diabetes pathogenesis; however, reports have been mixed on the contribution of MSR1 in obesity and glucose intolerance. We observed increased MSR1 expression in VAT of obese diabetic individuals compared to non-diabetic and single nuclear RNA sequencing identified macrophage-specific expression of MSR1 in human adipose tissue. We examined male Msr1(-/-) (Msr1KO) and WT controls and observed protection from obesity and AT inflammation in non-littermate Msr1KO mice. We then evaluated obese littermate Msr1(+/-) (Msr1HET) and Msr1KO mice. Both Msr1KO mice and Msr1HET mice became obese and insulin resistant when compared to their normal chow diet counterparts, but there was no Msr1-dependent difference in body weight, glucose metabolism, or insulin resistance. Flow cytometry revealed no significant differences between genotypes in ATM subtypes or proliferation in male and female mice. We observed increased frequency of proliferating ATMs in obese female compared to male mice. Overall, we conclude that while MSR1 is a biomarker of diabetes status in human adipose tissue, in mice Msr1 is not required for obesity-associated insulin resistance or ATM accumulation.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance
    Harmon, Daniel B.
    Srikakulapu, Prasad
    Kaplan, Jennifer L.
    Oldham, Stephanie N.
    McSkimming, Chantel
    Garmey, James C.
    Perry, Heather M.
    Kirby, Jennifer L.
    Prohaska, Thomas A.
    Gonen, Ayelet
    Hallowell, Peter
    Schirmer, Bruce
    Tsimikas, Sotirios
    Taylor, Angela M.
    Witztum, Joseph L.
    McNamara, Coleen A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (04) : 682 - 691
  • [12] Preliminary evidence for obesity-associated insulin resistance in adolescents without elevations of inflammatory cytokines
    Cohen, Jessica I.
    Maayan, Lawrence
    Convit, Antonio
    DIABETOLOGY & METABOLIC SYNDROME, 2012, 4
  • [13] Microvascular Dysfunction: A Potential Mechanism in the Pathogenesis of Obesity-associated Insulin Resistance and Hypertension
    De Boer, Michiel P.
    Meijer, Rick I.
    Wijnstok, Nienke J.
    Jonk, Amy M.
    Houben, Alphons J.
    Stehouwer, Coen D.
    Smulders, Yvo M.
    Eringa, Etto C.
    Serne, Erik H.
    MICROCIRCULATION, 2012, 19 (01) : 5 - 18
  • [14] Obesity, inflammation, and insulin resistance
    Martins, Luana Mota
    Soares Oliveira, Ana Raquel
    Climaco Cruz, Kyria Jayanne
    Torres-Leal, Francisco Leonardo
    Marreiro, Dilina do Nascimento
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 50 (04) : 677 - 692
  • [15] Obesity-associated insulin resistance in skeletal muscle: Role of lipid accumulation and physical inactivity
    Eckardt, Kristin
    Taube, Annika
    Eckel, Juergen
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2011, 12 (03) : 163 - 172
  • [16] Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism
    Qiao, Xin
    Zhou, Zhuo-Chao
    Niu, Rui
    Su, Yu-Tong
    Sun, Yue
    Liu, Hong-Lei
    Teng, Jia-Lin
    Ye, Jun-Na
    Shi, Hui
    Yang, Cheng-De
    Cheng, Xiao-Bing
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [17] NOV/CCN3: A New Adipocytokine Involved in Obesity-Associated Insulin Resistance
    Martinerie, Cecile
    Garcia, Marie
    Do, Thi Thu Huong
    Antoine, Benedicte
    Moldes, Marthe
    Dorothee, Guillaume
    Kazazian, Chantal
    Auclair, Martine
    Buyse, Marion
    Ledent, Tatiana
    Marchal, Pierre-Olivier
    Fesatidou, Maria
    Beisseiche, Adrien
    Koseki, Haruhiko
    Hiraoka, Shuichi
    Chadjichristos, Christos Evangelos
    Blondeau, Bertrand
    Denis, Raphael Georges
    Luquet, Serge
    Feve, Bruno
    DIABETES, 2016, 65 (09) : 2502 - 2515
  • [18] Orexins mitigate obesity-associated dysfunctions in mice
    Blais, Anne
    Denis, Isabelle
    Andriamihaja, Mireille
    Gratio, Valerie
    Champeil-Potokar, Gaelle
    Laouirem, Samira
    Chassac, Anais
    Couvelard, Anne
    Paradis, Valerie
    Voisin, Thierry
    Davila, Anne-Marie
    Couvineau, Alain
    OBESITY, 2024, 32 (10) : 1897 - 1909
  • [19] Relationship of skeletal muscle inflammation with obesity and obesity-associated hyperinsulinemia in horses
    Banse, Heidi E.
    Holbrook, Todd C.
    Frank, Nicholas
    McFarlane, Dianne
    CANADIAN JOURNAL OF VETERINARY RESEARCH-REVUE CANADIENNE DE RECHERCHE VETERINAIRE, 2016, 80 (03): : 217 - 224
  • [20] Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin
    Mauer, Jan
    Chaurasia, Bhagirath
    Goldau, Julia
    Vogt, Merly C.
    Ruud, Johan
    Nguyen, Khoa D.
    Theurich, Sebastian
    Hausen, A. Christine
    Schmitz, Joel
    Broenneke, Hella S.
    Estevez, Emma
    Allen, Tamara L.
    Mesaros, Andrea
    Partridge, Linda
    Febbraio, Mark A.
    Chawla, Ajay
    Wunderlich, F. Thomas
    Bruening, Jens C.
    NATURE IMMUNOLOGY, 2014, 15 (05) : 423 - +